Title : Differential expression, function and prognostic value of miR-17-92 cluster in ER-positive and triple-negative breast cancer.

Pub. Date : 2020

PMID : 33096318






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Treatment with DPCPX, a selective ADORA1 antagonist, abolished the difference in the growth of control and miR-17-92 overexpressing MCF7 cells and identified ADORA1 as a key functional target of miR-17-92 in ERPBC. 1,3-dipropyl-8-cyclopentylxanthine miR-17-92a-1 cluster host gene Homo sapiens
2 Treatment with DPCPX, a selective ADORA1 antagonist, abolished the difference in the growth of control and miR-17-92 overexpressing MCF7 cells and identified ADORA1 as a key functional target of miR-17-92 in ERPBC. 1,3-dipropyl-8-cyclopentylxanthine miR-17-92a-1 cluster host gene Homo sapiens